Fayerweather Charles reduced its stake in CVS Health Corporation (NYSE:CVS) by 4.1% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 32,397 shares of the pharmacy operator’s stock after selling 1,387 shares during the quarter. CVS Health Corporation comprises about 3.5% of Fayerweather Charles’ portfolio, making the stock its 9th largest holding. Fayerweather Charles’ holdings in CVS Health Corporation were worth $2,607,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently made changes to their positions in CVS. Bank of America Corp DE raised its position in CVS Health Corporation by 1.8% during the 1st quarter. Bank of America Corp DE now owns 22,411,957 shares of the pharmacy operator’s stock worth $1,759,338,000 after buying an additional 398,999 shares during the last quarter. Macquarie Group Ltd. raised its position in CVS Health Corporation by 2.4% during the 1st quarter. Macquarie Group Ltd. now owns 9,752,261 shares of the pharmacy operator’s stock worth $765,534,000 after buying an additional 225,981 shares during the last quarter. Clearbridge Investments LLC raised its position in CVS Health Corporation by 6.8% during the 1st quarter. Clearbridge Investments LLC now owns 9,258,404 shares of the pharmacy operator’s stock worth $726,785,000 after buying an additional 589,646 shares during the last quarter. Pioneer Investment Management Inc. raised its position in CVS Health Corporation by 4.6% during the 1st quarter. Pioneer Investment Management Inc. now owns 8,033,087 shares of the pharmacy operator’s stock worth $630,598,000 after buying an additional 353,621 shares during the last quarter. Finally, Parnassus Investments CA raised its position in CVS Health Corporation by 2.9% during the 1st quarter. Parnassus Investments CA now owns 6,237,016 shares of the pharmacy operator’s stock worth $473,605,000 after buying an additional 175,695 shares during the last quarter. 81.55% of the stock is owned by hedge funds and other institutional investors.

A number of equities analysts have issued reports on CVS shares. Jefferies Group LLC reissued a “hold” rating and set a $82.00 price target on shares of CVS Health Corporation in a research report on Friday, June 9th. Vetr raised shares of CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $87.97 price target for the company in a research report on Wednesday, May 24th. Cowen and Company reissued an “outperform” rating and set a $86.00 price target on shares of CVS Health Corporation in a research report on Tuesday, June 13th. ValuEngine lowered shares of CVS Health Corporation from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Finally, Leerink Swann set a $90.00 price target on shares of CVS Health Corporation and gave the stock a “buy” rating in a research report on Tuesday, June 27th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and fourteen have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $90.83.

TRADEMARK VIOLATION WARNING: This piece was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/09/12/cvs-health-corporation-cvs-is-fayerweather-charles-9th-largest-position.html.

CVS Health Corporation (CVS) traded up 3.71% during midday trading on Tuesday, reaching $82.68. 4,337,973 shares of the company were exchanged. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $91.82. The company has a 50 day moving average of $78.37 and a 200-day moving average of $78.89. The company has a market capitalization of $84.05 billion, a price-to-earnings ratio of 16.47 and a beta of 0.92.

CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating analysts’ consensus estimates of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The business had revenue of $45.69 billion during the quarter, compared to analysts’ expectations of $45.36 billion. During the same quarter last year, the business posted $1.32 earnings per share. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. On average, equities research analysts anticipate that CVS Health Corporation will post $5.88 earnings per share for the current fiscal year.

In other news, Director Richard J. Swift sold 2,500 shares of the firm’s stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $79.62, for a total value of $199,050.00. Following the completion of the transaction, the director now owns 3,258 shares in the company, valued at $259,401.96. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Helena Foulkes sold 20,332 shares of the firm’s stock in a transaction on Monday, June 19th. The shares were sold at an average price of $76.98, for a total value of $1,565,157.36. Following the completion of the transaction, the executive vice president now owns 59,300 shares of the company’s stock, valued at approximately $4,564,914. The disclosure for this sale can be found here. In the last 90 days, insiders sold 43,165 shares of company stock valued at $3,390,847. Company insiders own 0.61% of the company’s stock.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.